We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nalge Nunc to Market BioCrystal's OptiCell

By HospiMedica staff writers
Posted on 21 Aug 2006
Nalge Nunc International Corporation (Rochester, NY, USA) has entered into a partnership with BioCrystal, Ltd. More...
(Westerville, OH, USA) and acquired global distribution rights of OptiCell and related new products. OptiCell was developed by BioCrystal for cell cultures. The product will be sold and supported globally through the Nalge Nunc international distribution network under the brand name Nunc OptiCell.

The OptiCell device consists of gas-permeable polymer membranes that provide a cell culture growth surface area enclosed within a sealed environment. It accommodates adherent or non-adherent cells and enables visual access to living cells using standard imaging equipment. OptiCell's culture chamber enables cell growth on two parallel, gas-permeable membranes with only 10 ml of cell culture media or reagents.

A rack of 20 OptiCells provides growth surface equivalent to 27 T-75 (75 cm2) culture flasks, in one-fifth the incubation space. Self-sealing access ports greatly reduce risk of contamination, and the clear crystal polystyrene membrane allows high quality imaging of cells. Membranes can be sectioned, making OptiCell useful for cytostaining, transfection, and single cell cloning. The device is ideal for continuous monoclonal antibody production.

Nalge Nunc International is engaged in the design, development, and manufacture of plastic products for use in labware, packaging, biotechnology, and life science applications. "We are pleased to have joined with BioCrystal in bringing this exciting technology to the biomedical research community,” said Steve Silverman, vice president, marketing and product development, Nalge Nunc. "OptiCell further expands the available technologies we provide for in vitro cell culture,” he added.



Related Links:
Nalge Nunc
BioCrystal

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Repetitive Pipette
VWR® Stepper Pro
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.